Log In
Print
BCIQ
Print
Print this Print this
 

AFM11

  Manage Alerts
Collapse Summary General Information
Company Affimed N.V.
DescriptionTetravalent bispecific human antibody targeting CD19 and CD3
Molecular Target CD19 ; CD3
Mechanism of ActionBinds CD19; Binds CD3
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationNon-Hodgkin's lymphoma (NHL)
Indication DetailsTreat non-Hodgkin's lymphoma (NHL)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today